SRX Share Price

Open 15.00 Change Price %
High 15.00 1 Day -0.65 -4.30
Low 14.44 1 Week -0.16 -1.09
Close 14.48 1 Month 0.06 0.42
Volume 416776 1 Year -15.12 -51.08
52 Week High 30.22
52 Week Low 10.45
SRX Important Levels
Resistance 2 15.00
Resistance 1 14.79
Pivot 14.64
Support 1 14.17
Support 2 13.96
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
CDT 0.04 0.00%
LYC 0.21 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
AIR 0.06 200.00%
AIR 0.06 200.00%
AIR 0.06 200.00%
AIR 0.06 200.00%
RMG 0.02 100.00%
RMG 0.02 100.00%
CVS 0.02 100.00%
CVS 0.02 100.00%
CVS 0.02 100.00%
More..
ASX Australia Top Losers Stocks
RRP 0.08 -90.59%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
AVD 0.01 -50.00%
AVD 0.01 -50.00%
AVD 0.01 -50.00%
AOK 0.01 -50.00%
More..

Sirtex Medical Ltd (ASX: SRX)

SRX Technical Analysis 3
As on 16th Oct 2017 SRX Share Price closed @ 14.48 and we RECOMMEND Sell for LONG-TERM with Stoploss of 16.38 & Sell for SHORT-TERM with Stoploss of 15.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
SRX Target for October
1st Target up-side 14.79
2nd Target up-side 15.79
3rd Target up-side 16.79
1st Target down-side 11.93
2nd Target down-side 10.93
3rd Target down-side 9.93
SRX Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.sirtex.com
SRX Address
SRX
101 Miller Street
Level 33
Sydney, NSW 2060
Australia
Phone: 61 2 9964 8400
Fax: 61 2 9964 8410
SRX Latest News
Interactive Technical Analysis Chart Sirtex Medical Ltd ( SRX ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sirtex Medical Ltd
SRX Business Profile
Sirtex Medical Limited, a biotechnology and medical device company, is engaged in the research, development, manufacture, and distribution of liver cancer treatments utilizing small particle technology. It offers SIR-Spheres microspheres, a medical device used to deliver targeted internal radiation therapy, which contains radioactive yttrium-90 for the treatment of liver cancer. The company markets its products in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. Sirtex Medical Limited has a collaboration agreement with Guerbet S.A. to evaluate the unmet clinical need in patients with hepatocellular carcinoma, metastatic colorectal cancer, neuroendocrine tumors, and a range of other secondary liver cancers. The company is headquartered in Sydney, Australia.